KAYA17

KAYA17 is a Point-Of-Care Testing developer which has developed a 15-minute rapid Covid-19 saliva test. This test has an accuracy of 98% sensitivity and 100% specificity. Kaya17 is currently pending FDA approval for EUA of an Antigen test, and should hear back early 2021.